letters to the editorHigh-dose intrathecal trastuzumab for leptomeningeal metastases secondary to HER-2 overexpressing breast cancer
Under an Elsevier user license
open archive
Cited by (0)
Copyright © 2008 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved.